Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Shares Outstanding (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Shares Outstanding for 16 consecutive years, with $14.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding changed 0.05% to $14.9 million in Q4 2025 year-over-year; TTM through Nov 2025 was $14.9 million, a 0.05% change, with the full-year FY2025 number at $14.9 million, changed 0.05% from a year prior.
  • Shares Outstanding was $14.9 million for Q4 2025 at Cryo Cell International, roughly flat from $14.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $14.9 million in Q3 2025 to a low of $13.7 million in Q1 2021.
  • A 5-year average of $14.7 million and a median of $14.8 million in 2022 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: grew 7.57% in 2021, then grew 0.0% in 2024.
  • Cryo Cell International's Shares Outstanding stood at $14.7 million in 2021, then rose by 1.24% to $14.8 million in 2022, then increased by 0.01% to $14.8 million in 2023, then rose by 0.14% to $14.9 million in 2024, then increased by 0.05% to $14.9 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Shares Outstanding are $14.9 million (Q4 2025), $14.9 million (Q3 2025), and $14.9 million (Q2 2025).